2009
DOI: 10.1016/j.jss.2008.06.005
|View full text |Cite
|
Sign up to set email alerts
|

Correlations Between Neoadjuvant Treatment, Anemia, and Perioperative Complications in Patients Undergoing Esophagectomy for Cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
29
1
2

Year Published

2010
2010
2023
2023

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 35 publications
(33 citation statements)
references
References 31 publications
(40 reference statements)
1
29
1
2
Order By: Relevance
“…Characteristics of the included studies are summarized in Table . A total of 949 445 patients were included, and all 24 studies reported the primary outcome of 30‐day or in‐hospital mortality.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Characteristics of the included studies are summarized in Table . A total of 949 445 patients were included, and all 24 studies reported the primary outcome of 30‐day or in‐hospital mortality.…”
Section: Resultsmentioning
confidence: 99%
“…However, stroke and myocardial infarction were reported as an outcome only in studies of patients undergoing cardiac surgery ( Table ). A haemoglobin definition was used in 17 studies, a haematocrit definition in six studies, and both definitions were used in one study. Definitions of anaemia ranged from a haemoglobin concentration of 11 to 12 g/dl or a haematocrit of 30–39 per cent for female patients, and from 11 to 14 g/dl or 30–39 per cent respectively for male patients.…”
Section: Resultsmentioning
confidence: 99%
“…Preoperative anemia is common in esophageal cancer and is a risk factor in itself for a worse clinical outcome, as well as a strong predisposing factor for perioperative blood transfusion, which in turn increases morbidity, mortality, and costs [70][71][72]. Detection, diagnosis, and proper treatment of anemia are central in the concept of preoperative blood management in surgical patients [70].…”
Section: Potential Novel Pre-optimization Targetsmentioning
confidence: 99%
“…49,50 Therapeutic options include iron and erythropoietin (EPO). 49,50 Therapeutic options include iron and erythropoietin (EPO).…”
Section: Preoperative Hemoglobin Optimizationmentioning
confidence: 99%